Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Titel:
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Auteur:
Lipton, Richard B Croop, Robert Stock, David A Madonia, Jennifer Forshaw, Micaela Lovegren, Meghan Mosher, Linda Coric, Vladimir Goadsby, Peter J